Anti-TNF, a magic bullet in cancer immunotherapy?

Immune checkpoint blockers (ICB) have revolutionized cancer therapy. However, complete response is observed in a minority of patients and most patients develop immune-related adverse events (irAEs). These include colitis, which can be treated with anti-tumor necrosis factor (TNF) antibodies such as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Montfort, Anne, Dufau, Carine, Colacios, Céline, Andrieu-Abadie, Nathalie, Levade, Thierry, Filleron, Thomas, Delord, Jean-Pierre, Ayyoub, Maha, Meyer, Nicolas, Ségui, Bruno
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6857159/
https://ncbi.nlm.nih.gov/pubmed/31727152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0802-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados